AeroVax: study protocol for a randomised, double-blind, placebo-controlled, phase 2 trial to evaluate safety and immunogenicity of a next-generation COVID-19 vaccine delivered by inhaled aerosol to humans
AeroVax:一项随机、双盲、安慰剂对照的II期临床试验方案,旨在评估通过吸入气溶胶途径向人类递送的下一代COVID-19疫苗的安全性和免疫原性。
期刊:Erj Open Research
影响因子:4
doi:10.1183/23120541.00758-2024
Komorowski, Adam S; Mbuagbaw, Lawrence; Jeyanathan, Mangalakumari; Afkhami, Sam; Swinton, Marilyn; D'Agostino, Michael R; Howie, Karen; Medina, Maria Fe C; Gauvreau, Gail M; Brister, Danica L; Satia, Imran; Lichty, Brian D; Miller, Matthew S; Cameron, Donald W; Halperin, Scott; Thabane, Lehana; Loeb, Mark; Xing, Zhou; Smaill, Fiona M